Palisade Bio, Inc. (PALI) earnings
PALI earnings moved a median of -0.94% by the close. Quarterly and annual PALI reports and results, each read against the price at its own news timestamp. Back to the PALI overview →
16 measured PALI earnings events.
Where these PALI earnings landedvs 15 measured PALI earnings reactions
| Middle 50% of PALI earnings reactions | -3.31% to +1.98% |
|---|---|
| Median reaction (to close) | -0.94% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 PALI earnings events with a measured close landed between -3.31% and +1.98%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PALISADE BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | +1.04% | -2.60% | |
| Palisade Bio Reports First Quarter 2026 Financial Results and Highlights Continued Clinical Progress of PALI-2108 | Press release | +1.04% | -2.60% | |
| Form 10-K PALISADE BIO, INC. For: Dec 31 | SEC filing · Form 10-K | -0.26% | +0.00% | |
| Form 10-Q PALISADE BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | +0.85% | +3.41% | |
| Form 10-Q PALISADE BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | -2.05% | — | |
| Form 10-Q PALISADE BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | -6.34% | -8.74% | |
| Form 10-K PALISADE BIO, INC. For: Dec 31 | SEC filing · Form 10-K | -3.67% | -4.02% | |
| Form 10-Q PALISADE BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.19% | -5.18% | |
| Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108 | Press release | +1.21% | -4.03% | |
| Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | -0.81% | +0.54% | |
| Form 10-Q PALISADE BIO, INC. For: Jun 30 | SEC filing · Form 10-Q | -0.81% | +0.54% | |
| Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | +0.71% | +4.00% | |
| Form 10-Q PALISADE BIO, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.71% | +4.00% | |
| Form 10-K PALISADE BIO, INC. For: Dec 31 | SEC filing · Form 10-K | +0.84% | +4.03% | |
| Palisade Bio Reports Third Quarter 2023 Financial Results and Provides Business Outlook | Press release | -1.87% | -0.94% | |
| Form 10-Q PALISADE BIO, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.87% | -0.94% |
Keep exploring
More PALI: analyst actions → · SEC filings → · PALI overview →